Characteristics and reasons associated with non-acceptance of selective serotonin reuptake inhibitor treatment

被引：0
|
作者：
van Geffen, Erica Cg [1 ]
van Hulten, Rolf [1 ]
Bouvy, Marcel L. [2 ]
Egberts, Antoine C. G. [1 ]
Heerdink, Eibert R. [1 ]
机构：
[1] Utrecht Inst Pharmaceut Sci, Dept Pharmacoepidemiol & Pharmacotherapy, Utrecht, Netherlands
[2] SIR Inst Pharm & Policy, Leiden, Netherlands
来源：
PHARMACY WORLD & SCIENCE | 2008年 / 30卷 / 05期
关键词：
antidepressants; discontinuation; nonadherence;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：658 / 658
页数：1
相关论文
共 50 条
  • [1] Characteristics and reasons associated with nonacceptance of selective serotonin-reuptake inhibitor treatment
    van Geffen, Erica C. G.
    van Hulten, Rolf
    Bouvy, Marcel L.
    Egberts, Antoine C. G.
    Heerdink, Eibert R.
    ANNALS OF PHARMACOTHERAPY, 2008, 42 (02) : 218 - 225
  • [2] Characteristics associated with non-acceptance of antidepressant treatment
    Van Geffen, Erica C. G.
    Van Hulten, Rolf
    Bouvy, Marcel L.
    Egberts, Antoine C. G.
    Heerdink, Eibert R.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S221 - S222
  • [3] Characteristics and reasons associated with nonacceptance of selective serotonin-reuptake inhibitor treatment (vol 42, pg 218, 2008)
    van Geffen, E. C. G.
    ANNALS OF PHARMACOTHERAPY, 2008, 42 (03) : 451 - 451
  • [4] Selective Serotonin Reuptake Inhibitor Treatment and Depression Are Associated with Poststroke Mortality
    Ried, L. Douglas
    Jia, Huanguang
    Feng, Hua
    Cameon, Randi
    Wang, Xinping
    Tueth, Michael
    Wu, Samuel S.
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (7-8) : 888 - 897
  • [5] Reasons for non-acceptance of living kidney donors
    FehrmanEkholm, I
    Gabel, H
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (06) : 3526 - 3526
  • [6] Treatment of verbal agitation with a selective serotonin reuptake inhibitor
    Ramadan, FH
    Naughton, BJ
    Bassanelli, AG
    JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2000, 13 (02) : 56 - 59
  • [7] Selective serotonin reuptake inhibitor or serotonin-norepinephrine reuptake inhibitors and epidemiological characteristics associated with prenatal diagnosis of congenital heart disease
    Melov, Sarah J.
    Shetty, Prayatna Singh
    Pasupathy, Dharmintra
    Kirby, Adrienne
    Sholler, Gary F.
    Winlaw, David S.
    Alahakoon, Thushari, I
    PRENATAL DIAGNOSIS, 2021, 41 (01) : 35 - 42
  • [8] Dysbindin associated with selective serotonin reuptake inhibitor antidepressant efficacy
    Pae, Chi-Un
    Serretti, Alessandro
    Mandelli, Laura
    De Ronchi, Diana
    Patkar, Ashwin A.
    Jun, Tae-Youn
    Kim, Jung-Jin
    Lee, Chang-Uk
    Lee, Soo-Jung
    Lee, Chul
    Paik, In-Ho
    PHARMACOGENETICS AND GENOMICS, 2007, 17 (01): : 69 - 75
  • [9] Duloxetine, dual serotonin and norepinephrine reuptake inhibitor, versus paroxetine, selective serotonin reuptake inhibitor, in the treatment for premature ejaculation
    Levent Ozcan
    Emre Can Polat
    Alper Otunctemur
    Emin Ozbek
    International Urology and Nephrology, 2015, 47 : 283 - 287
  • [10] Duloxetine, dual serotonin and norepinephrine reuptake inhibitor, versus paroxetine, selective serotonin reuptake inhibitor, in the treatment for premature ejaculation
    Ozcan, Levent
    Polat, Emre Can
    Otunctemur, Alper
    Ozbek, Emin
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2015, 47 (02) : 283 - 287
12345